Followers | 263 |
Posts | 32937 |
Boards Moderated | 2 |
Alias Born | 01/24/2013 |
Tuesday, April 02, 2024 3:06:02 PM
*** Authorized Shares 40 Billion ***
For previous record of shares, refer to post #98842
This begins 10-10-23, the day a R/S takes effect. (1:1000 @ .00015)
Outstanding:
Before - 33,360,984,221
After - 33,360,985
10-17-23 - 33,361,150 OS { As per T/A}
165 shares added since 10-10-23
10-19-23 - 34,548,861 OS {As per 303auburn}
1,187,711 shares diluted since 10-17-23
10-20-23 - 36,213,574 OS {As per OTC}
1,664,713 shares diluted since 10-19-23
10-27-23 - 38,108,771 OS {As per OTC}
1,895,197 shares diluted since 10-20-23
11-06-23 - 38,784,446 OS {As per OTC}
675,675 shares diluted since 10-27-23
11-17-23 - 40,763,149 OS {As per T/A}
1,978,703 shares diluted since 11-06-23
11-28-23 - 43,293,522 OS { As per T/A}
2,530,373 shares diluted since 11-17-23
11-30-23 - 46,471,022 OS { As per OTC} Leaving for the record, but corrected in next entry.
3,177,500 shares diluted since 11-28-23
12-12-23 - 45,471,022 OS {As per T/A} He states that the OTC page "must be a typo" on their end.
2,177,500 shares diluted since 11-28-23
12-15-23 - 51,093,602 OS {As per OTC}
5,622,580 shares dilute since 12-12-23
12-22-23 - 54,520,830 OS {As per Ribo/OTC}
3,427,228 shares diluted since 12-15-23
01-04-24 - 59,008,539 OS { As per T/A}
4,487,709 shares diluted since 12-22-24
01-22-24 - 66,541,170 OS { As per T/A}
7,532,631 shares diluted since 01-04-24
01-23-24 - 70,041,170 OS { As per OTC}
3,500,000 shares diluted since 01-22-24
02-02-24 - 72,041,170 OS { As per T/A}
2,000,000,shares diluted since 01-23-24
02-21-24 - 88,124,406 OS { As per T/A}
16,083,233 shares diluted since 02-02-24
03-01-24 - 91,624,403 OS { As per OTC}
3,499,997 shares diluted since 02-21-24
03-08-24 - 94,135,819 OS {As per OTC}
2,511,416 shares diluted since 03-01-24
03-15-24 - 95,810,988 OS { As per OTC}
1,675,169 shares diluted since 03-08-24
03-22-24 - 104,791,556 OS {As per OTC}
8,980,568 shares diluted since 03-15-24
03-28-24 - 109,541,556 OS {As per OTC}
4,750,000 shares diluted since 03-22-24
A sure sign that the debate has been won:
When the response is an attack against the other person.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM